Personnel Information

写真a

KANEGANE Hirokazu


Job title

Professor

Research Areas, Keywords

primary immunodeficiency disease

Graduating School 【 display / non-display

  • Kanazawa University, Faculty of Medicine, 1986.03, Graduated

Graduate School 【 display / non-display

  • Kanazawa University, Graduate School, Division of Medicine, Doctor's Course, 1991.03, Completed

Campus Career 【 display / non-display

  • 2014.10
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Bio-Environmental Response, Pediatrics and Developmental Biology, Associate Professor
  • 2018.04
    -
    2018.06
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Bio-Environmental Response, Pediatrics and Developmental Biology, Associate Professor
  • 2018.07
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Endowed Departments, Department of Child Health and Development, Professor

Research Areas 【 display / non-display

  • Pediatrics

Qualification Acquired 【 display / non-display

  • Doctor

 

Published Papers & Misc 【 display / non-display

  • Akira Nishimura, Takuya Naruto, Satoshi Miyamoto, Andrew Grigg, Julian J Bosco, Akihiro Hoshino, Keishiro Amano, Shotaro Iwamoto, Masahiro Hirayama, Masahiro Migita, Osamu Ohara, Masatoshi Takagi, Tomohiro Morio, Menno C van Zelm, Hirokazu Kanegane. Genomics analysis of leukaemia predisposition in X-linked agammaglobulinaemia. Br J Haematol. 2021.04; ( PubMed, DOI )

  • Takao Karasawa, Ko Kudo, Kay Tanita, Yoshihiro Takahashi, Hirokazu Kanegane, Kiminori Terui. Epstein-Barr Virus-Negative Granulomatous Disease Due to SAP Deficiency. J Clin Immunol. 2021.04; ( PubMed, DOI )

  • Saori Kadowaki, Kunio Hashimoto, Toyoki Nishimura, Kenichi Kashimada, Tomonori Kadowaki, Norio Kawamoto, Kohsuke Imai, Satoshi Okada, Hirokazu Kanegane, Hidenori Ohnishi. Functional analysis of novel A20 variants in patients with atypical inflammatory diseases. Arthritis Res Ther. 2021.02; 23 (1): 52. ( PubMed, DOI )

  • Nishimura A, Aoki Y, Ishiwata Y, Ichimura T, Ueyama J, Kawahara Y, Tomoda T, Inoue M, Matsumoto K, Inoue K, Hiroki H, Ono S, Yamashita M, Okano T, Tanaka-Kubota M, Ashiarai M, Miyamoto S, Miyawaki R, Yamagishi C, Tezuka M, Okawa T, Hoshino A, Endo A, Yasuhara M, Kamiya T, Mitsuiki N, Ono T, Isoda T, Yanagimachi M, Tomizawa D, Nagasawa M, Mizutani S, Kajiwara M, Takagi M, Kanegane H, Imai K, Morio T. Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency Diseases. Journal of clinical immunology. 2021.02; ( PubMed, DOI )

  • Ziqing Ye, Wenhui Hu, Bingbing Wu, Yueping Zhang, Caixia Lei, Isabelle Williams, Dror S Shouval, Hirokazu Kanegane, Kyung Mo Kim, Lissy de Ridder, Neil Shah, Galina Ling, Baruch Yerushalmi, Daniel Kotlarz, Scott Snapper, Ruth Horn, Christoph Klein, Aleixo M Muise, Ying Huang, Holm H Uhlig. Predictive Prenatal Diagnosis for Infantile-onset Inflammatory Bowel Disease Because of Interleukin-10 Signalling Defects. J Pediatr Gastroenterol Nutr. 2021.02; 72 (2): 276-281. ( PubMed, DOI )

display all >>

Books etc 【 display / non-display

  • Aghamohammadi A, Plebani A, Lougaris V, DurandynA, Condino-Neto A, Kanegane H, Hammarstrom L. Primary Immunodeficiency Diseases. Springer, 2017.01 Predominantly Antibody Deficiencies (ISBN : 978-3-662-52907-2)

Conference Activities & Talks 【 display / non-display

  • Hirokazu Kanegane. Revisiting X-linked agammaglobulinemia. 12th International Congress of Immunodeficiency Diseases(ICID) 2021.04.27 Web開催

  • A study of adenosine deaminase 2 deficiency by multi-omics analysis. 2021.02.07

  • Delayed recovery of chimeric status after non-myeloablative cord blood transplantation in a patient with DNA ligase IV deficiency. 2021.02.06

  • Allogeneic hematopoietic stem cell transplantation from haploidentical donors for non-malignant diseases with post-transplantation cyclophosphamide and anti-thymoglobulin. 2020.11.22

  • Inflammatory bowel disease associated with XIAP deficiency can be cured by allogeneic hematopoietic cell transplantation. 2020.11.22

display all >>